These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13493550)

  • 1. Transaminases of Leishmania donovani, the causative organism of kala-azar.
    CHATTERJEE AN; GHOSH JJ
    Nature; 1957 Dec; 180(4599):1425. PubMed ID: 13493550
    [No Abstract]   [Full Text] [Related]  

  • 2. Leishmania donovani donovani and Leishmania donovani chagasi as antigens in a direct agglutination assay for the diagnosis of kala-azar.
    Andrade CR; Nascimento AE; Moura PM; Andrade PP
    Braz J Med Biol Res; 1989; 22(5):611-5. PubMed ID: 2620171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic cycle of the kala-azar parasite, Leishmania donovani.
    CHAKRABORTY J; DAS GUPTA NN
    J Gen Microbiol; 1962 Jul; 28():541-5. PubMed ID: 13877898
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytochemical studies of mitochondria in leptomonad form of Leishmania donovani, the kala-azar parasite.
    GUHA A; PYNE CK; SEN BB
    J Histochem Cytochem; 1956 May; 4(3):212-6. PubMed ID: 13332233
    [No Abstract]   [Full Text] [Related]  

  • 6. The causative organism of infantile kala-azar in Egypt.
    Killick-Kendrick R
    Trans R Soc Trop Med Hyg; 1985; 79(5):737-8. PubMed ID: 4095759
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on the structure of Leishmania donovani; the kala-azar parasite.
    DAS GUPTA NN; GUHA A; DE ML
    Exp Cell Res; 1954 May; 6(2):353-60. PubMed ID: 13173489
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis of chronic kala-azar and morphology of Leishmania donovani].
    DUIC M
    Vojnosanit Pregl; 1951; 8(9-10):327-32. PubMed ID: 14893730
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of kala-azar in dogs experimentally infected with Leishmania donovani].
    SIMITCH T; PETROVITCH Z; BORDJOCHKI A; POP-CENITCH S
    Arch Inst Pasteur Alger; 1957 Dec; 35(4):372-81. PubMed ID: 13522254
    [No Abstract]   [Full Text] [Related]  

  • 11. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Leishmania isolated from patients with kala-azar and post kala-azar dermal leishmaniasis in Bangladesh.
    el-Masum MA; Evans DA
    Trans R Soc Trop Med Hyg; 1995; 89(3):331-2. PubMed ID: 7660453
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
    Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
    Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-Kala-azar dermal leishmaniasis due to Leishmania donovani in Europe--case report.
    Antunes J; da Costa JB; Guimarães M; Vaz-Pinto I; Soares-Almeida L; Filipe P
    Int J Dermatol; 2013 Dec; 52(12):1584-6. PubMed ID: 24261735
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of a co-factor on the dynamics of Leishmania donovani infection: does HIV infection encourage the recurrence of visceral leishmaniasis following post-kala-azar dermal leishmaniasis?
    Nandy A; Addy M; Maji AK; Guha SK
    Ann Trop Med Parasitol; 2004 Sep; 98(6):651-4. PubMed ID: 15324473
    [No Abstract]   [Full Text] [Related]  

  • 17. ELISA titres to polysaccharide antigens of Leishmania donovani promastigotes in kala-azar.
    Ray R; Ghose AC
    Trans R Soc Trop Med Hyg; 1986; 80(6):998. PubMed ID: 3603654
    [No Abstract]   [Full Text] [Related]  

  • 18. L. (L.) chagasi in AIDS and visceral leishmaniasis (kala-azar) co-infection.
    Roselino AM; Chociay MF; Costa RS; Machado AA; Figueiredo JF
    Rev Inst Med Trop Sao Paulo; 2008; 50(4):251-4. PubMed ID: 18813767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct enzyme-linked immunosorbent assay: a simple immunoassay using Leishmania donovani promastigote for diagnosis of kala-azar.
    Mukerji K; Pal A; Basu D; Naskar K; Mallick KK; Ghosh DK
    J Clin Lab Anal; 1991; 5(4):299-301. PubMed ID: 1890544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Leishmania donovani isolates from different kala-azar foci in China by kDNA hybridization.
    Hu X; Lu H; Luo P; Wang Z; Hu X; Yi T
    Chin Med Sci J; 1992 Jun; 7(2):63-6. PubMed ID: 1450394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.